본문 바로가기

OTC Gene in Ornithine Transcarbamylase Deficiency: Clinical Course and Mutational Spectrum in Seven Korean Patients

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
PEDIATRIC NEUROLOGY51(3) · pp.354 · 2014
피인용
Web of Science 8
JCR IF
JCR 2013 1.504
ISSN
0887-8994

저자

  1. Lee, Jung Hyun제1저자고신대학교, Gospel Hosp, Dept Pediat, KO
  2. Kim, Gu-Hwan울산대학교, Dept Pediat Med Genet Clin & Lab, Childrens Hosp, KO
  3. Yoo, Han-Wook울산대학교, Dept Pediat Med Genet Clin & Lab, Childrens Hosp, KO
  4. 전종근교신저자부산대학교, 부산대학교병원, 대학병원, KO

초록

BACKGROUND: Ornithine transcarbamylase deficiency, an inborn error of metabolism, is the most common urea cycle disorder and is caused by mutations in the OTC gene located on Xp21. In this study, the clinical and genetic characteristics of seven Korean patients with ornithine transcarbamylase deficiency were analyzed. METHODS: During 2009-2012, a total of seven patients (three male and four female patients) from six-unrelated families were diagnosed with ornithine transcarbamylase deficiency by biochemical or molecular analysis. OTC gene sequencing analysis was performed in six of these patients. Clinical manifestations, clinical courses, and the results of genetic studies were reviewed retrospectively. RESULTS: The median follow-up period for the seven patients with ornithine transcarbamylase deficiency was 44 months (11.9-150 months). Clinical manifestations of ornithine transcarbamylase deficiency included vomiting and seizure, which were the most frequent signs at admission. Two of the four heterozygous female patients (50%) experienced severe neurological sequelae. The early onset male patient characterized severe neurological deficits. The late-onset male patient recovered completely from acute encephalopathy and coma without any neurological deficits. Direct sequencing and multiplex ligation-dependent probe amplification analysis of OTC gene revealed five different mutations. Of these mutations, two were novel (c.867-3T>C and c.664_667delinsAC). CONCLUSION: Ornithine transcarbamylase deficiency was genetically heterogeneous in the seven Korean patients with confirmed ornithine transcarbamylase deficiency diagnosis by biochemical findings and/or genetic analysis, together with two novel mutations in the OTC gene. We hope that these data will contribute to a better understanding of the clinical course and distinct molecular genetic characteristics of Korean patients with ornithine transcarbamylase deficiency.

키워드

ornithine transcarbamylase deficiencyOTC genedirect sequencingmultiple ligation-dependent probe amplificationUREA CYCLE DISORDERSPOLYMORPHISMS

식별자

WoS UID
000341335000011